Ledger.Open graph →
SEC Form D · filed October 4, 2023

Lexaria Bioscience Corp

Offering
$1.6M
Sold
$1.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
KELOWNA, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

John Docherty · KELOWNA, British Columbia, CanadaExec · DirectorAndrew Salter · San Marino, CAExec · DirectorNicholas Baxter · Kelowna, British Columbia, CanadaDirectorCatherine Turkel · Kelowna, British Columbia, CanadaDirectorAlbert E. Reese · Kelowna, British Columbia, CanadaDirectorChristopher Bunka · Kelowna, British Columbia, CanadaExec · DirectorTed Mckechnie · Kelowna, British Columbia, CanadaDirectorAngel Vazquez · Miguel Hidalgo, CDMX, O5Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗